Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
The future of IVL | Aetna's big coverage decision | Cardiology pioneer dies at 91 | FDA approves 2 devices | TAVR & cancer
Wednesday, January 7, 2026
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

Why Shockwave Medical is so excited about the future of intravascular lithotripsy

Nick West, MD, Shockwave Medical's chief medical officer, detailed how the company is continuing to push IVL technologies forward. "We are leading the space ... we have no intention of giving up that position," he said.

READ MORE >
Nick West, MD, chief medical officer, Shockwave Medical, Johnson and Johnson Meditech, explains how the company is innovating intravascular lithotripsy (IVL) therapy devices and building clinical evidence from trials for its use in a variety of calcified lesions. There are several companies developing IVL therapy, but West says Shockwave will remain the market leader because of its nearly decade long head start in the market, strong clinical evidence and has about a 10% market penetration. #IVKL
Share on Twitter Share on Facebook Share on Linkedin

Why Shockwave Medical is so excited about the future of intravascular lithotripsy

Share on Twitter Share on Facebook Share on Linkedin
Nick West, MD, chief medical officer, Shockwave Medical, Johnson and Johnson Meditech, explains how the company is innovating intravascular lithotripsy (IVL) therapy devices and building clinical evidence from trials for its use in a variety of calcified lesions. There are several companies developing IVL therapy, but West says Shockwave will remain the market leader because of its nearly decade long head start in the market, strong clinical evidence and has about a 10% market penetration. #IVKL
Nick West, MD, Shockwave Medical's chief medical officer, detailed how the company is continuing to push IVL technologies forward. "We are leading the space ... we have no intention of giving up that position," he said.
READ MORE >

Aetna covers AI-powered coronary plaque assessments, joining other major insurers

This news follows similar announcements from Humana, Cigna and UnitedHealthcare; a majority of insured Americans can now be treated with these technologies and have the procedure covered by their provider. 

READ MORE >
insurance
Share on Twitter Share on Facebook Share on Linkedin

Aetna covers AI-powered coronary plaque assessments, joining other major insurers

Share on Twitter Share on Facebook Share on Linkedin
insurance
This news follows similar announcements from Humana, Cigna and UnitedHealthcare; a majority of insured Americans can now be treated with these technologies and have the procedure covered by their provider. 
READ MORE >

Cardiology pioneer Thomas Fogarty dies as 91

Fogarty created many inventions that fundamentally changed cardiac surgical practice. He also received the Presidential Medal of Technology and Innovation from President Barack Obama in 2014.

READ MORE >
Cardiac surgeon and innovator Thomas Fogerty, MD, who was awarded the Presidential Medal of Technology.
Share on Twitter Share on Facebook Share on Linkedin

Cardiology pioneer Thomas Fogarty dies as 91

Share on Twitter Share on Facebook Share on Linkedin
Cardiac surgeon and innovator Thomas Fogerty, MD, who was awarded the Presidential Medal of Technology.
Fogarty created many inventions that fundamentally changed cardiac surgical practice. He also received the Presidential Medal of Technology and Innovation from President Barack Obama in 2014.
READ MORE >

Stereotaxis gains FDA approval for new robotically navigated cardiac ablation catheter

This new-look RF ablation catheter moves through the use of computer-controlled magnets, providing electrophysiologists with improved maneuverability and precision.  

READ MORE >
Magic Magnetic Interventional Ablation Catheter
Share on Twitter Share on Facebook Share on Linkedin

Stereotaxis gains FDA approval for new robotically navigated cardiac ablation catheter

Share on Twitter Share on Facebook Share on Linkedin
Magic Magnetic Interventional Ablation Catheter
This new-look RF ablation catheter moves through the use of computer-controlled magnets, providing electrophysiologists with improved maneuverability and precision.  
READ MORE >

FDA approves new stent for deep venous disease

According to Gore, the newly approved device was built with conformability, strength and fracture resistance in mind. 

READ MORE >
Gore Viabahn Fortegra Venous Stent
Share on Twitter Share on Facebook Share on Linkedin

FDA approves new stent for deep venous disease

Share on Twitter Share on Facebook Share on Linkedin
Gore Viabahn Fortegra Venous Stent
According to Gore, the newly approved device was built with conformability, strength and fracture resistance in mind. 
READ MORE >

TAVR remains a viable treatment strategy for cancer patients

Improvements in care have resulted in a growing number of patients who go on to be diagnosed with both cancer and severe aortic stenosis. TAVR appears to be an effective treatment option for those individuals, and it may help them go on to receive life-saving cancer therapies.

READ MORE >
doctorwithpatient.jpg
Share on Twitter Share on Facebook Share on Linkedin

TAVR remains a viable treatment strategy for cancer patients

Share on Twitter Share on Facebook Share on Linkedin
doctorwithpatient.jpg
Improvements in care have resulted in a growing number of patients who go on to be diagnosed with both cancer and severe aortic stenosis. TAVR appears to be an effective treatment option for those individuals, and it may help them go on to receive life-saving cancer therapies.
READ MORE >

Featured Articles

Trump regrets undergoing CT to evaluate heart health—cardiologist still baffled by his aspirin use

President Trump, 79, says he is still in excellent health. He also has no intention of cutting down on the high dose of aspirin he takes each day.

READ MORE >
President Trump
Share on Twitter Share on Facebook Share on Linkedin

Trump regrets undergoing CT to evaluate heart health—cardiologist still baffled by his aspirin use

Share on Twitter Share on Facebook Share on Linkedin
President Trump
President Trump, 79, says he is still in excellent health. He also has no intention of cutting down on the high dose of aspirin he takes each day.
READ MORE >

FDA confirms new recall after catheter sheath was left in patient’s body

This is a Class I recall, which means the FDA believes these devices could cause a serious injury or death.

READ MORE >
the words "FDA recall" on a board
Share on Twitter Share on Facebook Share on Linkedin

FDA confirms new recall after catheter sheath was left in patient’s body

Share on Twitter Share on Facebook Share on Linkedin
the words "FDA recall" on a board
This is a Class I recall, which means the FDA believes these devices could cause a serious injury or death.
READ MORE >

W. L. Gore & Associates to acquire medtech company behind foam-based LAAO system

Conformal Medical developed its CLAAS technology to help patients with nonvalvular atrial fibrillation reduce their risk of stroke without the use of anticoagulants. Back in August, the company raised $32 million to help ramp up research on the device.

READ MORE >
Healthcare M&A, mergers and acquisitions business deal.
Share on Twitter Share on Facebook Share on Linkedin

W. L. Gore & Associates to acquire medtech company behind foam-based LAAO system

Share on Twitter Share on Facebook Share on Linkedin
Healthcare M&A, mergers and acquisitions business deal.
Conformal Medical developed its CLAAS technology to help patients with nonvalvular atrial fibrillation reduce their risk of stroke without the use of anticoagulants. Back in August, the company raised $32 million to help ramp up research on the device.
READ MORE >

FDA approves TMVR system from Edwards Lifesciences for high-risk heart patients

The Sapien M3 transcatheter mitral valve replacement system is implanted using a transseptal approach. The device previously received CE mark approval in 2025.

READ MORE >
The Sapien M3 system for transcatheter mitral valve replacement. Image courtesy of Edwards Lifesciences.
Share on Twitter Share on Facebook Share on Linkedin

FDA approves TMVR system from Edwards Lifesciences for high-risk heart patients

Share on Twitter Share on Facebook Share on Linkedin
The Sapien M3 system for transcatheter mitral valve replacement. Image courtesy of Edwards Lifesciences.
The Sapien M3 transcatheter mitral valve replacement system is implanted using a transseptal approach. The device previously received CE mark approval in 2025.
READ MORE >

Positron raises $2M to expand PET-CT commercialization

The New York-based imaging company is now focused on expanding sales for the cost-effective PET-CT system it developed with Neusoft Medical Systems.

READ MORE >
Positron NeuSight PET-CT 64 slice scanner
Share on Twitter Share on Facebook Share on Linkedin

Positron raises $2M to expand PET-CT commercialization

Share on Twitter Share on Facebook Share on Linkedin
Positron NeuSight PET-CT 64 slice scanner
The New York-based imaging company is now focused on expanding sales for the cost-effective PET-CT system it developed with Neusoft Medical Systems.
READ MORE >

In Case You Missed It

Reimbursement expected to drive implementation of CCTA, coronary plaque analysis

For years, imaging experts have predicted that CCTA may become the primary imaging modality for coronary artery disease and eliminate the need for invasive diagnostic catheterizations. That prediction is now coming true.

READ MORE >
HeartFlow Plaque analysis AI software highlighting areas of interest in the coronaries with significant plaque burden and showing a cross sectional reformatted view with plaques. Demo at TCT 2024. DF
Share on Twitter Share on Facebook Share on Linkedin

Reimbursement expected to drive implementation of CCTA, coronary plaque analysis

Share on Twitter Share on Facebook Share on Linkedin
HeartFlow Plaque analysis AI software highlighting areas of interest in the coronaries with significant plaque burden and showing a cross sectional reformatted view with plaques. Demo at TCT 2024. DF
For years, imaging experts have predicted that CCTA may become the primary imaging modality for coronary artery disease and eliminate the need for invasive diagnostic catheterizations. That prediction is now coming true.
READ MORE >

Cardiologist reportedly fired over role with CDC vaccine panel—wife calls it a ‘staggering turn of events’

Kirk Milhoan, MD, PhD, has been fired from his role as a pediatric cardiologist. His wife and others say he was let go because he is now the chair of the CDC’s Advisory Committee on Immunization Practices.

READ MORE >
Kirk Milhoan, MD, PhD, a veteran physician who was recently named the chair of the CDC’s Advisory Committee on Immunization Practices (ACIP), has reportedly been fired from his day-to-day role as a pediatric cardiologist.
Share on Twitter Share on Facebook Share on Linkedin

Cardiologist reportedly fired over role with CDC vaccine panel—wife calls it a ‘staggering turn of events’

Share on Twitter Share on Facebook Share on Linkedin
Kirk Milhoan, MD, PhD, a veteran physician who was recently named the chair of the CDC’s Advisory Committee on Immunization Practices (ACIP), has reportedly been fired from his day-to-day role as a pediatric cardiologist.
Kirk Milhoan, MD, PhD, has been fired from his role as a pediatric cardiologist. His wife and others say he was let go because he is now the chair of the CDC’s Advisory Committee on Immunization Practices.
READ MORE >

AI-powered FFR-CT software linked to considerable cost savings, accurate predictions

According to Heartflow, its AI offering saves health systems nearly $1,400 per patient thanks to reductions in unnecessary cardiovascular testing.

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

AI-powered FFR-CT software linked to considerable cost savings, accurate predictions

Share on Twitter Share on Facebook Share on Linkedin
According to Heartflow, its AI offering saves health systems nearly $1,400 per patient thanks to reductions in unnecessary cardiovascular testing.
READ MORE >

In Other News

FDA recalls surgical packs due to risk of microbial contamination

Multiple lots of ophthalmic surgery packs manufactured by Alcon will need to be disposed of, due to an incomplete seal that could cause the sterile bandages and syringes inside to be compromised. Because of the serious health risk posed to patients, this recall has been designated Class I. 

READ MORE >
U.S. FDA Sign
Share on Twitter Share on Facebook Share on Linkedin

FDA recalls surgical packs due to risk of microbial contamination

Share on Twitter Share on Facebook Share on Linkedin
U.S. FDA Sign
Multiple lots of ophthalmic surgery packs manufactured by Alcon will need to be disposed of, due to an incomplete seal that could cause the sterile bandages and syringes inside to be compromised. Because of the serious health risk posed to patients, this recall has been designated Class I. 
READ MORE >

New healthcare private equity reporting requirements set to go into effect

HealthExec zooms in on laws passed in Massachusetts, Oregon and California that are set to change how hedge funds interact with patient care organizations.

READ MORE >
private equity corporatization business consolidation
Share on Twitter Share on Facebook Share on Linkedin

New healthcare private equity reporting requirements set to go into effect

Share on Twitter Share on Facebook Share on Linkedin
private equity corporatization business consolidation
HealthExec zooms in on laws passed in Massachusetts, Oregon and California that are set to change how hedge funds interact with patient care organizations.
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

Medtech giant makes big move | The world’s top hospitals for heart surgery | New CPT codes | PET vs. SPECT | TAVR tech recalled
AI is gaining ground, but clinicians run the show | Siemens Healthineers doubles down | Electrophysiologist compensation
News Alert: FDA shares warning about heart valve tech after patient death
Cardiologist pay & productivity are up | FDA clears PE thrombectomy devices | Cardiology tech in spotlight | Gore's new approval
Cardiology salaries on the rise | The climbing costs of care | M&A trends | Siemens Healthineers, J&J make big business moves
Major MRI trends | Blood thinner recalled | When to perform PCI before TAVR | How to build a CCTA program | Steroids & the heart
CMS boosts coverage for heart failure tech | FDA approves CardioMEMS updates | LVADs linked to strokes, other risks
Newsletter archive
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
  • Press Releases
  • Submit Press Release
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
Design by Adaptive Theme
Trimed Popup